The global ECG telemetry devices market size reached US$ 5.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.7 Billion by 2028, exhibiting a growth rate (CAGR) of 8.2% during 2023-2028.
Electrocardiography (ECG) telemetry devices enable rapid ECG monitoring of patients with suspected cardiovascular diseases (CVDs). They help detect electrical impulses generated by cardiac tissues, which are subsequently translated into waveforms. They find extensive applications in hospitals and home healthcare services. At present, the increasing prevalence of CVDs, such as heart attacks and strokes, due to alcohol and tobacco consumption, obesity, and physical inactivity among individuals is catalyzing the demand for ECG telemetry devices across the globe.
ECG Telemetry Devices Market Trends:
ECG telemetry devices are used in the diagnosis and treatment of arrhythmia wherein the heart rate of an individual becomes abnormal. These devices offer information about fluctuations in the rhythm of the heart that allows doctors to take required actions. Apart from this, ECG telemetry devices comprise resting ECGs, which are utilized for identifying conditions, such as coronary artery disease (CAD) or congestive heart failure (CHF). This, along with the thriving healthcare industry, is strengthening the growth of the market. Besides this, there is a significant rise in the utilization of health monitoring devices like electrocardiographs, digital thermometers, automatic blood pressure monitors, blood glucose monitors, and body fat monitors in the residential sector. They can be operated by patients or their caretakers with minimal training. Furthermore, coronavirus disease (COVID-19) affects the cardiovascular system and leads to myocardial damage and cardiac and endothelial dysfunction. This, coupled with the increasing geriatric population, is propelling the demand for ECG telemetry devices around the world. Other factors, including rising technological advancements and the growing awareness about cardiovascular health among the masses, are projected to influencing the overall sales and profitability positively in the coming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global ECG telemetry devicesmarket report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application and end user.
Breakup by Product:
Event Monitoring and MCT (Mobile Cardiac Telemetry)
Breakup by Application:
Myocardial Ischemia and Infarction
Breakup by End User:
Breakup by Region:
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Aerotel Medical Systems (1998) Ltd., Compumed Inc., Hill-Rom Holdings Inc. (Baxter International Inc.), iRhythm Technologies Inc., Koninklijke Philips N.V., Medicalgorithmics S.A., Medtronic plc, Nihon Kohden Corporation, Preventice Solutions Inc. (Boston Scientific Corporation), ScottCare Cardiovascular Solutions, Shenzhen Mindray Bio-Medical Electronics Co. Ltd. and ZOLL Medical Corporation (Asahi Kasei Corporation).
Base Year of the Analysis
Product, Application, End User, Region
Asia Pacific, Europe, North America, Latin America, Middle East and Africa
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Aerotel Medical Systems (1998) Ltd., Compumed Inc., Hill-Rom Holdings Inc. (Baxter International Inc.), iRhythm Technologies Inc., Koninklijke Philips N.V., Medicalgorithmics S.A., Medtronic plc, Nihon Kohden Corporation, Preventice Solutions Inc. (Boston Scientific Corporation), ScottCare Cardiovascular Solutions, Shenzhen Mindray Bio-Medical Electronics Co. Ltd. and ZOLL Medical Corporation (Asahi Kasei Corporation)
10% Free Customization
Report Price and Purchase Option
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report
The global ECG telemetry devices market was valued at US$
5.3 Billion in 2022.
We expect the global ECG telemetry devices market to exhibit a CAGR of
8.2% during 2023-2028.
The sudden outbreak of the COVID-19 pandemic has led the increasing requirement for ECG telemetry devices to monitor the coronavirus-infected patients, as it affects the cardiovascular system and can cause myocardial damage as well as cardiac and endothelial dysfunction.
The rising prevalence of CVDs, such as heart attacks and strokes, along with the growing adoption of ECG telemetry devices for diagnosing and treating arrhythmia, wherein the heart rate of an individual becomes abnormal, is primarily driving the global ECG telemetry devices market.
Based on the product, the global ECG telemetry devices market has been categorized into event monitoring and MCT (Mobile Cardiac Telemetry) and others. Currently, event monitoring and MCT (Mobile Cardiac Telemetry) accounts for the majority of the total market share.
Based on the application, the global ECG telemetry devices market can be segregated into arrhythmias, myocardial ischemia and infarction, pacemaker monitoring, and others. Among these, arrhythmias hold the largest market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global ECG telemetry devices market include Aerotel Medical Systems (1998) Ltd., Compumed Inc., Hill-Rom Holdings Inc. (Baxter International Inc.), iRhythm Technologies Inc., Koninklijke Philips N.V., Medicalgorithmics S.A., Medtronic plc, Nihon Kohden Corporation, Preventice Solutions Inc. (Boston Scientific Corporation), ScottCare Cardiovascular Solutions, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., and ZOLL Medical Corporation (Asahi Kasei Corporation).
Need more help?
Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.